A phase IV, multicentre, open-label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures.

Creator(s)

Miguel Escobar
Amy Dunn
Doris Quon
Ben Trzaskoma
Lucy Lee
Richard H. Ko
Shannon L. Carpenter, Children's Mercy HospitalFollow

Document Type

Article

Publication Date

7-2022

Identifier

DOI: 10.1111/hae.14574

Journal Title

Haemophilia : the official journal of the World Federation of Hemophilia

Volume

28

Issue

4

First Page

105

Last Page

108

Recommended Citation

Escobar M, Dunn A, Quon D, et al. A phase IV, multicentre, open-label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures. Haemophilia. 2022;28(4):e105-e108. doi:10.1111/hae.14574